Latest News

Heliocare Launched in Rexall PharmaPlus Nationwide!
BASIS Medical Technologies and NETWORK Globalhealth announce new partnership agreement.
"Strataderm Scar Therapy in the News"

Events

Basis To Attend 2014 CSAPS! More Info To Come, Stay Tuned!
The 75th Annual American Academy of Dermatology

Featuring the patented SCA technology, Endocare provides advanced skin regeneration and repair.

SCA is a natural secretion derived from the mollusc Cryptomphalus aspersa obtained through a carefully controlled pharmacological process. A natural source of complex of proteic factors, SCA has been shown to have a strong regenerative effect on skin damaged by photaging, radiation or dermatological treatments.

SCA is formulated under the EndoCare and Tensage brands and is ideal for use post-laser treatment and as part of a daily anti-aging regimen.  Specifically, SCA has been shown to stimulate the biochemical, structural and functional processes of the skin, including:

  • Fibroblast proliferation
  • Assembly of extracellular matrix
  • Collagenase activity
  • Antioxidant activity

 

The elegant Endocare and Tensage formulations are distinguished by a biorepair index, indicating their regenerative potency. Available for full-face, body, eyes and lips, the SCA range of products combine cosmetic appeal and efficacy for noticeably younger, healthier skin.